Similar articles

• Rates of cardiac catheterization, coronary angioplasty and coronary artery bypass surgery in Canada.

  Higginson LA, Naylor CD. Higginson LA, et al. Can J Cardiol. 1997 Dec;13 Suppl D:47D-52D. Can J Cardiol. 1997. PMID: 9444308 Review. No abstract available.
• [The waiting time for heart interventions: trends for percutaneous coronary interventions and cardiothoracic interventions].

  Huijskes RV, Koch KT, van Herwerden LA, Berreklouw E, Limburg M, Tijssen JG. Huijskes RV, et al. Ned Tijdschr Geneeskd. 2003 Sep 20;147(38):1860-5. Ned Tijdschr Geneeskd. 2003. PMID: 14533500 Dutch.
• Troubling lesion subsets: bifurcation disease.

  [No authors listed] [No authors listed] J Invasive Cardiol. 2002 Dec;14(12):773-5. J Invasive Cardiol. 2002. PMID: 12537004 No abstract available.
• Disease progression and adverse events in patients listed for elective percutaneous coronary intervention.

  Talwar S, Karpha M, Thomas R, Vurwerk C, Cox IC, Burrell CJ, Motwani JG, Gilbert TJ, Haywood GA. Talwar S, et al. Postgrad Med J. 2005 Jul;81(957):459-62. doi: 10.1136/pgmj.2004.031344. Postgrad Med J. 2005. PMID: 15998823 Free PMC article.
• Advances in percutaneous coronary intervention.

  Pompa JJ, Wang JC. Pompa JJ, et al. Adv Intern Med. 2001;46:307-58. Adv Intern Med. 2001. PMID: 11147257 Review. No abstract available.